Your browser doesn't support javascript.
loading
New Interventional Treatment Model for Pancreatic Neoplasms Using Gemcitabine-Eluting Hydrogel Devices: In Vitro and In Vivo Results.
Lopez-Benitez, Ruben; Benz, David; Wu, Yue; Wu, Xinping; Chen, Samuel; Cruise, Gregory M.
Affiliation
  • Lopez-Benitez R; Department of Radiology, Luzerner Kantonsspital, 6000, Luzern 16, Switzerland. ruben.lopezbenitez@luks.ch.
  • Benz D; Department of Radiology, Luzerner Kantonsspital, 6000, Luzern 16, Switzerland.
  • Wu Y; MicroVention, Inc., 1311 Valencia, Tustin, CA, 92780, USA.
  • Wu X; MicroVention, Inc., 1311 Valencia, Tustin, CA, 92780, USA.
  • Chen S; MicroVention, Inc., 1311 Valencia, Tustin, CA, 92780, USA.
  • Cruise GM; MicroVention, Inc., 1311 Valencia, Tustin, CA, 92780, USA.
Cardiovasc Intervent Radiol ; 40(8): 1246-1254, 2017 Aug.
Article in En | MEDLINE | ID: mdl-28314923

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreas / Pancreatic Neoplasms / Adenocarcinoma / Drug Delivery Systems / Hydrogel, Polyethylene Glycol Dimethacrylate / Deoxycytidine / Vascular Access Devices Limits: Animals Language: En Journal: Cardiovasc Intervent Radiol Year: 2017 Document type: Article Affiliation country: Suiza Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreas / Pancreatic Neoplasms / Adenocarcinoma / Drug Delivery Systems / Hydrogel, Polyethylene Glycol Dimethacrylate / Deoxycytidine / Vascular Access Devices Limits: Animals Language: En Journal: Cardiovasc Intervent Radiol Year: 2017 Document type: Article Affiliation country: Suiza Country of publication: Estados Unidos